• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Prescription Medications May Do Little to Encourage CPAP Use

by Jennifer Decker Arevalo, MA • March 1, 2007

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

CPAP usage (effective mask pressure based on hours per day) was recorded by an internal data chip during the four-week trial. Patient symptoms were assessed with the Epworth Sleepiness Scale (ESS) and Functional Outcomes of Sleep Questionnaire (FOSQ). Treatment groups were matched for age, body mass index, and baseline ESS and FOSQ scores.

You Might Also Like

  • Day One Postoperative Use of CPAP Well Tolerated in Sinonasal Surgery Patients
  • Temporary Trial May Improve Compliance with CPAP
  • Persistent OSA After Adenotonsillectomy in CPAP-Intolerant Children: What to Do Next?
  • Early Birds Have More Success with Using CPAP for Longer Periods
Explore This Issue
March 2007
Mark J. Rosen, MD

Mark J. Rosen, MD

Despite randomization, the standard care group had a significantly higher apnea-hypopnea index (AHI) than either the zolpidem or placebo pill groups. Compared with the placebo pill and standard care groups, the zolpidem group did not show greater CPAP usage in terms of total days used or average time used per night. When the initial 14 days of CPAP treatment were analyzed separately, there was also no difference in the number of days used or average nightly use. Although average nightly CPAP usage within the zolpidem group was higher in the initial 14 days than in the subsequent 14 days, this did not reach statistical significance. There was also no difference across the three groups in the number of regular users, or patients who used CPAP on at least 70% of nights and averaged at least four hours per night.

Although all three CPAP treatment groups showed significant symptom improvement, as measured by the ESS and FOSQ, an oral hypnotic agent did not increase initial CPAP compliance in new users and Dr. Bradshaw and his fellow authors could not recommend empiric treatment.

OSA Insomnia Patients

However, since studies have shown that almost half of patients with OSA have insomnia complaints, the researchers believe prescription sleep medications, when used correctly, may prove helpful for a subset of patients with OSA insomnia.

Insomnia is the most common sleep disorder and there is a complex relationship between insomnia and OSA, said Dr. Kezirian. Sometimes, OSA contributes to insomnia and treating OSA can improve sleep patterns, whereas other times, the effective treatment of OSA may actually worsen insomnia because the sleepiness associated with OSA overcomes the tendency to remain awake in bed without sleeping.

In general, sleep medications are not the best first-line treatment for OSA patients with insomnia, Dr. Kezirian added. These patients should receive treatment for both disorders. Sleep medications can be part of a treatment plan for insomnia, but these patients should not receive sleep medications without treatment of OSA because the medications can actually worsen breathing patterns during sleep. In some cases, effective treatment of OSA alone can eliminate or at least simplify the treatment of insomnia because it eliminates the confounding effect of one disorder on another.

Pages: 1 2 3 | Single Page

Filed Under: Articles, Clinical, Features Issue: March 2007

You Might Also Like:

  • Day One Postoperative Use of CPAP Well Tolerated in Sinonasal Surgery Patients
  • Temporary Trial May Improve Compliance with CPAP
  • Persistent OSA After Adenotonsillectomy in CPAP-Intolerant Children: What to Do Next?
  • Early Birds Have More Success with Using CPAP for Longer Periods

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Excitement Around Gene Therapy for Hearing Restoration

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939